Related Experiment Video
Updated: Jul 11, 2026
04:56
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Novel p53/p130 axis in bladder tumors
Maria Mudryj1, Elizabeth Reay, Laurel Beckett
1Veterans Affairs Northern California Health Care System, Mather, California, USA. mmudryj@ucdavis.edu
Urology
|October 2, 2007
Summary
Researchers identified a new p53/p130 pathway in bladder tumors, revealing correlations between cell proliferation, apoptosis, and tumor suppressor proteins across different stages.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Understanding the molecular mechanisms driving bladder tumor progression is crucial for developing targeted therapies.
- Key cellular pathways, including proliferation and apoptosis, are dysregulated in cancer.
- Identifying novel protein interactions can elucidate tumor biology and suggest new therapeutic targets.
Purpose of the Study:
- To investigate the relationships between critical components of proliferative and apoptotic pathways in bladder tumors.
- To explore the expression patterns of specific proteins (p53, Rb, p27, cyclin E, Bcl-2) in relation to tumor stage and proliferation markers.
Main Methods:
- Utilized a tissue array of 88 bladder tumors for immunohistochemical analysis.
- Assessed expression of proliferation marker Ki67, apoptosis markers, and proteins p53, Rb, p130, cyclin E, and p27.
- Quantified protein expression as the percentage of positively staining cells in relation to tumor stage.
Main Results:
- p53 expression increased with tumor stage, while Rb and p27 decreased.
- Cyclin E levels correlated with proliferation (Ki67), showing stage-dependent variations.
- A strong correlation was observed between p53 and p130 expression, particularly in Stages 1 and 3.
Conclusions:
- Suggests a novel p53/p130 signaling axis in bladder tumorigenesis.
- Highlights the complex interplay of cell cycle regulators and tumor suppressors in bladder cancer.
- Provides a foundation for further research into the p53/p130 pathway for potential therapeutic strategies.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...